Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Classement en actions #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Prix de l'action
$152.37
Capitalisation boursière
$376.33B
Changement (1 jour)
12.46%
Changement (1 an)
79.41%
Pays
US
Échange Merck & Co., Inc. (MRK)

Catégorie

Ratio P/B pour Merck & Co., Inc. (MRK)
Ratio P/B au August 2026 TTM : 8.01
Selon les derniers rapports financiers et le cours de l'action de Merck & Co., Inc., le ratio cours/valeur comptable actuel (TTM) est 8.01. À la fin de 2024, le ratio P/B était de 5.44.
Historique du ratio P/B pour Merck & Co., Inc. de 2000 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 8.01 57.64%
2025 5.08 -6.51%
2024 5.44 -28.09%
2023 7.56 23.82%
2022 6.11 20.29%
2021 5.08 -34.85%
2020 7.79 -9.22%
2019 8.59 21.37%
2018 7.07 67.90%
2017 4.21 9.48%
2016 3.85 22.74%
2015 3.14 -0.75%
2014 3.16 12.54%
2013 2.81 25.96%
2012 2.23 11.14%
2011 2.01 2.50%
2010 1.96 57.27%
2009 1.24 -62.32%
2008 3.30 -50.09%
2007 6.61 28.29%
2006 5.16 39.08%
2005 3.71 -5.78%
2004 3.93 -37.81%
2003 6.33 -5.53%
2002 6.70 -16.24%
2001 7.99 -42.42%
2000 13.88 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
31.0864 288.19%
US
7.4766 -6.64%
US
-74.4354 -1,029.51%
US
8.4776 5.86%
CH
6.754 -15.66%
CH